Are you Dr. Robins?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7887 Almor Dr
Verona, WI 53593Phone+1 608-263-1416
Summary
- Dr. H Robins, MD is a hematologist in Verona, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Florida, and Illinois. He is affiliated with University Hospital.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1979 - 1982- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1976 - 1979
Boston University School of MedicineClass of 1976
Certifications & Licensure
WI State Medical License 1977 - 2025
FL State Medical License 2021 - 2023
IL State Medical License 1988 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2005 Dec 20
- Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 06
- A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab Start of enrollment: 2012 Dec 03
Publications & Presentations
PubMed
- Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825.Joshua D Strauss, Mark R Gilbert, Minesh Mehta, Ang Li, Renke Zhou Ms
Neuro-Oncology. 2024-11-16 - Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas.Colin M Harari, Adam R Burr, Brett A Morris, Wolfgang A Tomé, Adam Bayliss
Neuro-Oncology Advances. 2024-05-10 - 4 citationsNRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi
Neuro-Oncology Advances. 2023-10-11
Grant Support
- Phase I Trial Of Intravenous Thymidine And CarboplatinNational Center For Research Resources1995
- Phase I Evaluation Of IV Melphalan And Whole Body HyperthermiaNational Center For Research Resources1995
Professional Memberships
- Member
